Aemetis Stock Gets Increased EPS Estimate from HC Wainwright

Key Points

• HC Wainwright raised its FY2026 EPS estimate for Aemetis to a loss of $0.55 per share from a projected loss of $0.88, and forecast a return to profit in FY2028.
• Aemetis reported a quarterly loss of $0.02 per share, beating the $0.20 loss analysts expected; revenue of $88.15 million also exceeded the $74.20 million consensus.
• Analyst sentiment is mixed, with one Buy rating and one Sell rating; MarketBeat reports an overall Hold rating and an average price target of $11.88.

Aemetis, Inc (NASDAQ:AMTX - Free Report) - Investment analysts at HC Wainwright upped their FY2026 earnings per share (EPS) estimates for Aemetis in a research note issued to investors on Friday, November 6th. HC Wainwright analyst A. Dayal now forecasts that the specialty chemicals company will post earnings per share of ($0.55) for the year, up from their prior estimate of ($0.88). The consensus estimate for Aemetis' current full-year earnings is ($0.89) per share. HC Wainwright also issued estimates for Aemetis' Q4 2026 earnings at ($0.16) EPS, FY2027 earnings at ($0.28) EPS, FY2028 earnings at $0.74 EPS and FY2029 earnings at $2.15 EPS.

Aemetis (NASDAQ:AMTX - Get Free Report) last posted its earnings results on Thursday, November 5th. The specialty chemicals company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.18. The firm had revenue of $88.15 million during the quarter, compared to the consensus estimate of $74.20 million.

Other analysts have also recently issued reports about the stock. Wall Street Zen raised shares of Aemetis from a "sell" rating to a "hold" rating in a research note on Saturday, August 22nd. Weiss Ratings reiterated a "sell (e+)" rating on shares of Aemetis in a research note on Thursday, October 15th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $11.88.

Aemetis Stock Up 6.8%

Shares of AMTX stock opened at $1.73 on Tuesday. Aemetis has a 12-month low of $1.11 and a 12-month high of $3.80. The company has a market capitalization of $124.85 million, a P/E ratio of -3.09 and a beta of 1.87. The firm has a 50-day moving average price of $1.66 and a 200 day moving average price of $1.95.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Royal Bank of Canada raised its position in shares of Aemetis by 10,632.5% during the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company's stock worth $28,000 after acquiring an additional 8,825 shares during the last quarter. Sanctuary Advisors LLC bought a new position in Aemetis in the first quarter valued at about $33,000. R Squared Ltd boosted its holdings in Aemetis by 59.4% in the third quarter. R Squared Ltd now owns 23,616 shares of the specialty chemicals company's stock valued at $42,000 after acquiring an additional 8,803 shares during the last quarter. Lido Advisors LLC bought a new position in Aemetis in the third quarter valued at about $79,000. Finally, State of Wyoming acquired a new stake in Aemetis in the third quarter worth about $226,000. 27.02% of the stock is currently owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies.

The company's California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.